Pediatric solid tumors and second malignancies: characteristics and survival outcomes
- PMID: 19765728
- DOI: 10.1016/j.jss.2009.05.030
Pediatric solid tumors and second malignancies: characteristics and survival outcomes
Abstract
Background: To examine the incidence, characteristics, and outcomes for second malignancies following the diagnosis of a primary solid tumor in pediatric patients.
Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried from 1973 to 2005, excluding recurrences, in patients <20 y.
Results: A total of 31,685 cases of pediatric solid malignancies were identified. Overall, 177 patients were diagnosed with a unique second malignancy before the age 20 (0.56%) The mean follow-up was for 8.5 y (2 mo-30.8 y). Mean age at diagnosis of the primary tumor was 7.7 y. The most common primary malignancies were CNS tumors (22.5%), followed by soft tissue sarcoma (15.8%), retinoblastoma (14.1%), and bone tumors (13%). Hematologic malignancies (35.5%) were the most common second malignancies noted in the cohort, followed by bone tumors (18%) and soft tissue sarcomas (15%). Hematologic malignancies had a shorter latency (3.1 y) compared with solid second tumors (11.6 y). The overall 10-y survival for the entire cohort was 41.5%. For most tumor categories, development of a secondary malignancy was associated with lower 5- and 10-y survival than expected.
Conclusions: CNS tumors, retinoblastoma, and soft tissue sarcomas in children are the most common solid primary tumors, with an increased risk of a second malignancy. Leukemia is the most common second malignancy seen in pediatric solid tumors. Second malignancies are associated with significantly reduced survival rates compared with the general childhood cancer population.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.Acta Oncol. 2010;49(2):237-44. doi: 10.3109/02841860903253538. Acta Oncol. 2010. PMID: 20100158
-
Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.Cancer. 2010 Sep 15;116(18):4385-94. doi: 10.1002/cncr.25313. Cancer. 2010. PMID: 20549819
-
Ewing's sarcoma and the development of secondary malignancies.Clin Orthop Relat Res. 2003 Oct;(415):82-9. doi: 10.1097/01.blo.0000093900.12372.e4. Clin Orthop Relat Res. 2003. PMID: 14612633
-
A review of secondary central nervous system tumors after treatment of a primary pediatric malignancy.Semin Pediatr Neurol. 2012 Mar;19(1):43-8. doi: 10.1016/j.spen.2012.02.015. Semin Pediatr Neurol. 2012. PMID: 22641075 Review.
-
What's new in pediatric oncology? Epidemiology, treatment principles and prognosis in childhood malignancies.Pathol Res Pract. 1985 Jan;179(3):425-8. doi: 10.1016/S0344-0338(85)80153-9. Pathol Res Pract. 1985. PMID: 3885197 Review.
Cited by
-
Robotically assisted long bone biopsy under MRI: cadaver study results.Int J Comput Assist Radiol Surg. 2019 Jan;14(1):147-156. doi: 10.1007/s11548-018-1889-1. Epub 2018 Nov 19. Int J Comput Assist Radiol Surg. 2019. PMID: 30456451
-
Solid tumors in Turkish children: a multicenter study.World J Pediatr. 2013 Feb;9(1):25-31. doi: 10.1007/s12519-011-0323-3. Epub 2011 Nov 21. World J Pediatr. 2013. PMID: 22105573
-
Second cancers after childhood cancer--GPs beware!Scand J Prim Health Care. 2013 Sep;31(3):147-52. doi: 10.3109/02813432.2013.824152. Epub 2013 Aug 2. Scand J Prim Health Care. 2013. PMID: 23906108 Free PMC article.
-
Secondary ALL after Successful Treatment of Ewing's Sarcoma: A Case Report.Int J Hematol Oncol Stem Cell Res. 2016 Oct 1;10(4):236-238. Int J Hematol Oncol Stem Cell Res. 2016. PMID: 27928479 Free PMC article.
-
De novo formation of brain tumors in pediatric population following therapeutic cranial irradiation.Childs Nerv Syst. 2015 Jun;31(6):893-9. doi: 10.1007/s00381-015-2689-3. Epub 2015 Apr 2. Childs Nerv Syst. 2015. PMID: 25831997
MeSH terms
LinkOut - more resources
Full Text Sources